Evidence map›Paper›PMID 41738756›Full record

ArticlemBio2026

Vaccine-induced antibodies can limit

Marisol Perez-Toledo, Kubra Aksu-Istil, Edith Marcial-Juarez, Ruby R Persaud, Areej Alshayea, Sian E Jossi, Agostina Carestia, Fien von Meijenfeld, Marina Botto, Leo C James and 9 more

Abstract read
In one paragraph

Article in mBio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Marisol Perez-ToledoInstitute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.ORCID 0000-0002-5734-255X
Kubra Aksu-IstilInstitute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.
Edith Marcial-JuarezInstitute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.
Ruby R PersaudInstitute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.
Areej AlshayeaInstitute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.
Sian E JossiInstitute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.
Agostina CarestiaDepartment of Microbiology, Immunology and Infectious Diseases, Cumming School of Medicine, University of Calgary, Calgary, Canada.
Fien von MeijenfeldUniversity Medical Center Groningen, Groningen, the Netherlands.
Marina BottoDepartment of Immunology and Inflammation, Centre for Inflammatory Disease, Imperial College London, London, United Kingdom.
Leo C JamesMRC Laboratory of Molecular Biology, Cambridge, United Kingdom.
Bas SurewaardDepartment of Microbiology, Immunology and Infectious Diseases, Cumming School of Medicine, University of Calgary, Calgary, Canada.
Zaheer AfzalClinical Immunology Service, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.
Adrian M ShieldsClinical Immunology Service, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.
William G HorsnellDivision of Immunology, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
Constantino Lopez-MaciasMedical Research Unit in Immunochemistry, Specialty Hospital, National Medical Center Siglo XXI, Mexican Institute of Social Security, Mexico City, Mexico.
Ian R HendersonInstitute for Molecular Bioscience, University of Queensland, Brisbane, Australia.
OptiVaNTS consortium
Craig N JenneDepartment of Microbiology, Immunology and Infectious Diseases, Cumming School of Medicine, University of Calgary, Calgary, Canada.
Adam F CunninghamInstitute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.ORCID 0000-0003-0248-964X

Funding

Wellcome Trust 221431/Z/20/Z
6 · The paper itself

Abstract

Antibodies against

Indexed as

Antibodies, BacterialComplement System ProteinsMacrophagesSalmonella InfectionsSalmonella typhimuriumSalmonella VaccinesAnimalsFemaleHumansMiceMice, Inbred C57BLMice, KnockoutNeutrophilsSpleenAntibodies, BacterialComplement System ProteinsSalmonella Vaccinesantibodiescomplementintravital imagingmacrophagesneutrophilsSalmonella

Identifiers

PMID41738756
PMCPMC13059751

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.